{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06053567",
            "orgStudyIdInfo": {
                "id": "2016120049"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01CA273221",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01CA273221"
                }
            ],
            "organization": {
                "fullName": "University of Texas at Austin",
                "class": "OTHER"
            },
            "briefTitle": "Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.",
            "officialTitle": "Efficacy and Implementation of Exercise-based Smoking Cessation Treatment for Adults With High Anxiety Sensitivity.",
            "acronym": "STEP3",
            "therapeuticArea": [
                "Other"
            ],
            "study": "community-based-smoking-cessation-treatment-for-adults-with-high-stress-sensitivity"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-27",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-07",
            "studyFirstSubmitQcDate": "2023-09-13",
            "studyFirstPostDateStruct": {
                "date": "2023-09-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Jasper A. Smits",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "University of Texas at Austin"
            },
            "leadSponsor": {
                "name": "Jasper A. Smits",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "University of Houston",
                    "class": "OTHER"
                },
                {
                    "name": "University of Oklahoma",
                    "class": "OTHER"
                },
                {
                    "name": "National Cancer Institute (NCI)",
                    "class": "NIH"
                },
                {
                    "name": "YMCA",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Anxiety sensitivity, reflecting the fear of bodily sensations, is a risk factor for the maintenance and relapse of smoking. This study is designed to address the question - is a smoking cessation intervention personalized to high anxiety sensitive smokers and adapted for implementation by the YMCA effective among racially/ethnically diverse samples?",
            "detailedDescription": "This protocol provides the recommended treatment to achieve smoking cessation (i.e., counseling and nicotine replacement therapy) and randomly assigns individuals to a high-intensity exercise or low-intensity exercise intervention as a strategy to engage the mechanisms relevant to high anxiety sensitive smokers to improve smoking cessation outcomes."
        },
        "conditionsModule": {
            "conditions": [
                "Nicotine Dependence"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 360,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "High-Intensity Aerobic Exercise",
                    "type": "EXPERIMENTAL",
                    "description": "Participants assigned to this arm will be instructed to complete 75 minutes per week of aerobic training at 60-85% of the their heart rate reserve.",
                    "interventionNames": [
                        "Behavioral: Aerobic Exercise",
                        "Behavioral: Counseling",
                        "Drug: Nicotine patch"
                    ]
                },
                {
                    "label": "Low-Intensity Aerobic Exercise",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants assigned to this arm will be instructed to complete 75 minutes per week of aerobic training at 20-40% of the their heart rate reserve.",
                    "interventionNames": [
                        "Behavioral: Aerobic Exercise",
                        "Behavioral: Counseling",
                        "Drug: Nicotine patch"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Aerobic Exercise",
                    "description": "Participants will select a YMCA branch and will be assigned a personal fitness instructor who will oversee a 15-week exercise intervention. The weekly exercise prescription is 75 minutes of aerobic training.",
                    "armGroupLabels": [
                        "High-Intensity Aerobic Exercise",
                        "Low-Intensity Aerobic Exercise"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Counseling",
                    "description": "Participants will receive the standard tobacco cessation package of up to 5 proactive interactions from the Texas Tobacco Quitline (TTQ). Interactions are typically phone calls, but can be chat or live text if the participant prefers. Interaction 1 is for assessment and quit date planning, Interaction 2 occurs prior to the quit date and can be a group session, Interaction 3 occurs shortly following the quit date, and Interactions 4 and 5 are for relapse prevention if the smoker has quit or problem solving if they have not quit. TTQ also offers a tobacco cessation text messaging program and access to a web portal with a variety of cessation resources.",
                    "armGroupLabels": [
                        "High-Intensity Aerobic Exercise",
                        "Low-Intensity Aerobic Exercise"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Nicotine patch",
                    "description": "On the target quit day (week 6), participants will be provided 8 weeks of nicotine replacement therapy (24-hour transdermal nicotine patches \\[TNP\\]).",
                    "armGroupLabels": [
                        "High-Intensity Aerobic Exercise",
                        "Low-Intensity Aerobic Exercise"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "7-day point prevalence abstinence (PPA) at 6-month follow-up",
                    "description": "Self-report of no smoking (not even a puff) during the previous 7 days, verified by expired carbon monoxide (CO; \u22645ppm), saliva cotinine (\\<30 ng/mL), or significant other, and not invalidated by any of these verification measures. Failure to provide any of these 3 verification measures will result in PPA being considered missing.",
                    "timeFrame": "Protocol week 30, which is 24 weeks (6 months) after the quit attempt (set at week 6)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "7-day point prevalence abstinence (PPA) at 12-month follow-up",
                    "description": "Self-report of no smoking (not even a puff) during the previous 7 days, verified by expired carbon monoxide (CO; \u22645ppm), saliva cotinine (\\<30 ng/mL), or significant other, and not invalidated by any of these verification measures. Failure to provide any of these 3 verification measures will result in PPA being considered missing.",
                    "timeFrame": "Protocol week 54, which is 48 weeks (12 months) after the quit attempt (set at week 6)"
                },
                {
                    "measure": "7-day point prevalence abstinence (PPA) at 9-month follow-up",
                    "description": "Self-report of no smoking (not even a puff) during the previous 7 days, verified by expired carbon monoxide (CO; \u22645ppm), saliva cotinine (\\<30 ng/mL), or significant other, and not invalidated by any of these verification measures. Failure to provide any of these 3 verification measures will result in PPA being considered missing.",
                    "timeFrame": "Protocol week 42, which is 36 weeks (9 months) after the quit attempt (set at week 6)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult (age \u2265 18);\n* High Anxiety Sensitivity (\u22655 on the Short Scale Anxiety Sensitivity Index \\[SSASI\\]);\n* Daily smoker, \u22655 cigarettes (including e-cigarettes, little cigars/cigarillos) for \u22651 year;\n* Motivated to quit smoking as evidenced by a score of \u22655 on a 0-10 Likert scale;\n* Body mass index \\<40;\n* Medical clearance to participate.\n\nExclusion Criteria:\n\n* Regular exercise defined as engaging in moderate-intensity exercise \u22653 days per week for \u226520 min each time;\n* Receiving current intervention for smoking cessation.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Marla I Sarmiento, BS",
                    "role": "CONTACT",
                    "phone": "915-502-9979",
                    "email": "sarmimar@utexas.edu"
                },
                {
                    "name": "Sydney Thureen, BS",
                    "role": "CONTACT",
                    "phone": "610-719-7952",
                    "email": "sthureen@utexas.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jasper Smits, PhD",
                    "affiliation": "University of Texas at Austin",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Texas at Austin",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78712",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Within one year of completion (publication) of the primary aims for this project, we will provide de-identified data from this project to interested researchers. The data are to be provided in a SPSS file or Excel, with separate documentation of labels/characteristics for each column of data. Data will be released directly by Dr. Smits's team at UT to investigators providing evidence of their institution's IRB approval for planned analyses of the data.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF"
            ],
            "timeFrame": "Within one year of completion (publication) of the primary aims. No end date.",
            "accessCriteria": "Data will be released directly by Dr. Smits's team at UT to investigators providing evidence of their institution's IRB approval for planned analyses of the data."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014029",
                    "term": "Tobacco Use Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4324",
                    "name": "Anxiety Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M16785",
                    "name": "Tobacco Use Disorder",
                    "asFound": "Nicotine Dependence",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009538",
                    "term": "Nicotine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005731",
                    "term": "Ganglionic Stimulants"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018722",
                    "term": "Nicotinic Agonists"
                },
                {
                    "id": "D000018679",
                    "term": "Cholinergic Agonists"
                },
                {
                    "id": "D000018678",
                    "term": "Cholinergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12478",
                    "name": "Nicotine",
                    "asFound": "Assess",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4029",
                    "name": "Central Nervous System Stimulants",
                    "relevance": "LOW"
                },
                {
                    "id": "M20796",
                    "name": "Nicotinic Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20758",
                    "name": "Cholinergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                }
            ]
        }
    },
    "hasResults": false
}